Intuitive Surgical, Inc. $ISRG Shares Sold by Pacer Advisors Inc.

Posted by Stanley Muller on Jun 20th, 2026

Pacer Advisors Inc. cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 10.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,718 shares of the medical equipment provider’s stock after selling 6,542 shares during the quarter. Pacer Advisors Inc.’s holdings in Intuitive Surgical were worth $30,424,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the company. Kera Capital Partners Inc. lifted its holdings in Intuitive Surgical by 47.7% during the 4th quarter. Kera Capital Partners Inc. now owns 1,037 shares of the medical equipment provider’s stock worth $587,000 after buying an additional 335 shares in the last quarter. MV Capital Management Inc. purchased a new position in Intuitive Surgical in the fourth quarter valued at $300,000. Continental Investors Services Inc. raised its stake in Intuitive Surgical by 8.0% in the fourth quarter. Continental Investors Services Inc. now owns 594 shares of the medical equipment provider’s stock valued at $336,000 after buying an additional 44 shares in the last quarter. Cambient Family Office LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth about $10,164,000. Finally, McLaughlin Asset Management Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $1,602,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the sale, the director owned 120 shares of the company’s stock, valued at $55,620. This trade represents a 49.79% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,169 shares of company stock worth $3,059,135 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ISRG. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. TD Cowen dropped their price target on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Bank of America cut their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. UBS Group lowered their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $573.42.

View Our Latest Report on Intuitive Surgical

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $406.78 on Friday. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88. The stock has a 50 day moving average of $438.43 and a two-hundred day moving average of $490.46. The stock has a market cap of $144.07 billion, a P/E ratio of 49.31, a P/E/G ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same period last year, the firm posted $1.81 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.